Accueil › Cancer du sein › Virginie › Arlington
Essais cliniques pour Cancer du sein à Arlington, VA
46 études pour Cancer du sein recherchent des participants dans et autour de Arlington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Recrutement en coursPhase 2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Recrutement en coursPhase 1/2
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Virginia Cancer Specialists, PC, Fairfax · à 11 mi
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Recrutement en coursPhase 3
- Inova Schar Cancer Institute, Fairfax · à 11 mi
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Recrutement en coursPhase 2
- Inova Schar Cancer Institute, Fairfax · à 11 mi
Study of AVZO-021 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · à 11 mi
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Recrutement en coursPhase 3
- Inova Schar Cancer Institute ( Site 0025), Fairfax · à 11 mi
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Recrutement en coursPhase 3
- Research Site, Fairfax · à 11 mi
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Recrutement en coursPhase 2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Recrutement en cours
- Inova, Fairfax · à 11 mi
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Recrutement en coursPhase 3
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Recrutement en coursPhase 2
- Inova Schar Cancer Institute, Fairfax · à 11 mi
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
Recrutement en coursPhase 1
- Next Virginia, Fairfax · à 11 mi
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Recrutement en coursPhase 1/2
- NEXT Oncology, Fairfax · à 11 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Recrutement en coursPhase 3
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Virginia Cancer Specialists, Fairfax · à 11 mi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Recrutement en coursPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · à 11 mi
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, Fairfax · à 11 mi
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists-Fairfax, Fairfax · à 11 mi
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Recrutement en coursPhase 1/2
- Next Oncology, Fairfax · à 11 mi
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Recrutement en coursPhase 3
- Virginia Cancer Specialists, PC, Fairfax · à 11 mi
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Inova Fair Oaks Hospital, Fairfax · à 11 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Recrutement en coursPhase 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · à 5 mi
- Kaiser Permanente-Burke Medical Center, Burke · à 11 mi
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Inova Schar Cancer Institute, Falls Church · à 4 mi
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Recrutement en coursPhase 3
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Inova Fair Oaks Hospital, Fairfax · à 11 mi
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Recrutement en coursPhase 3
- Virginia Cancer Specialists, Fairfax · à 11 mi
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Recrutement en coursPhase 1/2
- USOR Virginia Cancer Specialists, Fairfax · à 11 mi
E-Mindfulness Approaches for Living After Breast Cancer
Recrutement en coursPhase 3
- Inova Fairfax Hospital, Falls Church · à 4 mi
- Kaiser Permanente Tysons Corner Medical Center, McLean · à 5 mi
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- et 1 autres
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · à 11 mi
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Recrutement en coursPhase 3
- INOVA Schar Cancer, Fairfax · à 11 mi
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- NEXT, Fairfax · à 11 mi
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Recrutement en coursPhase 1/2
- Inova Schar Cancer Institute ( Site 0051), Fairfax · à 11 mi
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Recrutement en coursPhase 3
- Virginia Cancer Specialists, PC, Reston · à 14 mi
- Virginia Cancer Specialists, Manassas · à 22 mi
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology Virginia, Fairfax · à 11 mi
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Recrutement en coursPhase 1/2
- NEXT, Virginia, Fairfax · à 11 mi
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Recrutement en coursPhase 1
- Inova Schar Cancer Center, Fairfax · à 11 mi
- NEXT Virginia, Fairfax · à 11 mi
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
Recrutement en coursPhase 1
- Biotheryx Investigative Site, Fairfax · à 11 mi
Essais pour Cancer du sein dans d'autres villes
- New York City, NY134 études
- Houston, TX126 études
- Boston, MA111 études
- Nashville, TN80 études
- Los Angeles, CA72 études
- Edison, NJ68 études
- St. Louis, MO64 études
- Durham, NC63 études
- Queens, NY63 études
- Chicago, IL58 études
- Philadelphia, PA56 études
- Dallas, TX55 études
Autres études à Arlington
- Cancer du poumon non à petites cellules104 études
- Cancer métastatique53 études
- Cancer colorectal52 études
- Cancer (tous types)48 études
- Cancer de l'ovaire46 études
- Cancer du poumon41 études
- Cancer de l'endomètre39 études
- Cancer du pancréas33 études
- Carcinome épidermoïde de la tête et du cou26 études
- Cancer bronchique à petites cellules23 études
- Cancer du sein triple négatif20 études
- Cancer de l'estomac20 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.